marijuana stocks news

V-Love Now Available Between the Sheets

 Enertopia Corporation (ENRT-OTCQB)(TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce V-LoveTM has been placed on the store shelves and is now available for purchase in Canada.

In only a few short months the Company has been able to bring its first natural wellness product to market. V-LoveTM sexual gel for women is now available for purchase at the Loblaws City Market, 1650 Lonsdale Avenue, North Vancouver, British Columbia, Canada. “We are excited to have V-LoveTM available for retail sale for our customers,” stated President, Robert McAllister.

Stay tuned for upcoming details on the V-LoveTM Launch Party being held at Loblaws City Market, 1650 Lonsdale Avenue. Enertopia is excited to be working with the Loblaws City Market, 1650 Lonsdale Avenue, North Vancouver, where we will be holding one of our educational sessions on women’s health education.

The Company will be providing updates to the public and shareholders as it expands its market outreach and programs in the upcoming weeks.

“Enertopia is fully committed to empowering people with a better way of living through healthy lifestyle choices in letting us help you live your life, your way,” Stated President Robert McAllister

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Endexx Corporation (EDXC) Lands Award for Best Advancements in Hemp Industry at Uptick Newswire’s Uppie Awards

Endexx Lands Award for Best Advancements in Hemp Industry at Uptick Newswire’s…

$AFI Closes 700,000 Units Private Placement

Affinor Growers Closes 700,000 Units Private Placement MONTREAL, CANADA–(Marketwired – Feb 11,…

$GWPH Initiates Phase 2 Clinical Study of Cannabidivarin (CBDV) in Epilepsy

GW Pharmaceuticals Initiates Phase 2 Clinical Study of Cannabidivarin (CBDV) in Epilepsy…

Plandai Biotechnology Inc. (PLPL) Provides Update to Its Proprietary Technology

Plandai Biotechnology Provides Update to Its Proprietary Technology Plandai Biotechnology Inc. (OTC…